Abstract

Background Erectile dysfunction (ED) is the inability to achieve and maintain a steady erection for sexual performance. Erectile dysfunction (ED) is becoming more common in the general population, particularly among elderly men with lower urinary tract symptoms and those with benign prostatic hyperplasia. This rise in erectile dysfunction has also been attributed by several other etiologies, which includes inflammatory, mechanical, psychological, occlusive vascular, trauma, endocrine, neurologic, chemical and extra factors (prostatectomy, old age). The purpose of the study was to assess erectile dysfunction in patients with benign prostate hyperplasia before treatment using international index of erectile function (IIEF) tool.

Methodology Hospital-based cross-sectional study from March 2021 to June 2022, which involved 188 patients clinically diagnosed with benign prostatic enlargement. Convenient sampling method was used to recruit participants and structured questionnaires were used to attain social demographic characteristics. The international prostate symptom score (IPSS) was used to assess, diagnose patients with BPH as well as the severity of LUTS and international index of erectile function (IIEF) was used to assess erectile dysfunction. Data was analyzed using SPSS software version 27.

Results The proportion of ED in patients with benign prostate hyperplasia/LUTS using IIEF tool was found to be 154(82%) and those with no erectile dysfunction was 34(18%). The factors that were statistically associated with erectile dysfunction were age, marital status, cigarette smoking, and diabetes mellitus.

Conclusion Erectile dysfunction is very common in men who have Benign Prostate Hyperplasia. The prevalence and severity of ED increased with age, diabetes, cigarette smoking, lower urinary tract symptoms, and hypertension, according to the study.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study received fund from Tanzania ministry of health

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was reviewed and approved by the Institution of Review Board of the Muhimbili University of Health and Allied Sciences (reference number DA.282/298/01.C/) and permission to collect data was obtained from relevant authorities at MNH.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The datasets analyzed during this study are available from the corresponding author on reasonable request.

AbbreviationsBPHBenign Prostate HyperplasiaEDErectile DysfunctionIIEFInternational Index of Erectile FunctionIPPSInternational Prostate Symptoms ScoreLUTSLower Urinary Tract SymptomsQoLQuality of LifeMNHMuhimbili National HospitalMUHASMuhimbili University of Health and Allied Sciences